List of Excipients in API metoprolol succinate er tablets
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing metoprolol succinate er tablets
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 | CELLULOSE, MICROCRYSTALLINE |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 | CROSCARMELLOSE SODIUM |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 | ETHYLCELLULOSE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for metoprolol succinate er tablets
Excipient focus: CELLULOSE, MICROCRYSTALLINE
metoprolol succinate er tablets drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
metoprolol succinate er tablets drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
metoprolol succinate er tablets drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
metoprolol succinate er tablets drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
metoprolol succinate er tablets drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
metoprolol succinate er tablets drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Quality Care Products LLC | metoprolol succinate er tablets | 55700-976 |
| Redpharm Drug Inc | metoprolol succinate er tablets | 67296-1470 |
| Ascend Laboratories LLC | metoprolol succinate er tablets | 67877-590 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
metoprolol succinate er tablets drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Quality Care Products LLC | metoprolol succinate er tablets | 55700-976 |
| Redpharm Drug Inc | metoprolol succinate er tablets | 67296-1470 |
| Ascend Laboratories LLC | metoprolol succinate er tablets | 67877-590 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLENE CHLORIDE
metoprolol succinate er tablets drug variants containing METHYLENE CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing METHYLENE CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
metoprolol succinate er tablets drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
metoprolol succinate er tablets drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
metoprolol succinate er tablets drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
metoprolol succinate er tablets drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
metoprolol succinate er tablets drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
metoprolol succinate er tablets drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
metoprolol succinate er tablets drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
metoprolol succinate er tablets drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
metoprolol succinate er tablets drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5720 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5721 |
| A-S Medication Solutions | metoprolol succinate er tablets | 50090-5722 |
| >Company | >Ingredient | >NDC |
metoprolol succinate er tablets drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
